Search
for
Sort by
Research 331–360 of 516
- Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing
- Heavy metals in biological samples of cancer patients: a systematic literature review
- An Updated Etiology of Hair Loss and the New Cosmeceutical Paradigm in Therapy: Clearing ‘the Big Eight Strikes’
- Sensitive Quantitative In Vivo Assay for Evaluating the Effects of Biomolecules on Hair Growth and Coloring Using Direct Microinjections into Mouse Whisker Follicles
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines
- Comparative Study of the Online Over-The-Counter Hair Loss Products
- Imaging to study solid tumour origin and progression: lessons from research and clinical oncology
- The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- The effects of phosphodiesterase 3 (PDE3) inhibitor on hair follicle cell viability and hair growth
- PD59-09 PHOSPHODIESTERASE INHIBITORS COULD REVERSE THE PROLIFERATION OF BPH EPITHELIAL CELLS INDUCED BY CD8+ T CELLS IN LOW ANDROGEN CONDITION
- Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor
- White Lupin Cluster Root Acclimation to Phosphorus Deficiency and Root Hair Development Involve Unique Glycerophosphodiester Phosphodiesterases
- Investigation, treatment and monitoring of late‐onset hypogonadism in males: ISA, ISSAM, and EAU recommendations
- Alopecia areata
- Lack of efficacy of apremilast in 9 patients with severe alopecia areata
- Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Effect of a transcriptional inactive or absent vitamin D receptor on beta-cell function and glucose homeostasis in mice
- Apremilast is efficacious in refractory alopecia areata
- The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
- Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review
- Alopecia areata: from pathophysiology to therapeutic innovation
- Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- Approaching Erectile Dysfunction in Dermatology Patients